Internal Medicine, Infectious Disease · Macon, GA
NPI
1538239389
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
707 Pine Street
Macon, GA, 31201
Phone (478) 301-5801
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
971 services
Medicare patients, 2024
250
Average age 70
Drug cost, 2024
$7.7M
3,810 prescriptions
Company payments, 2025
$22K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey L Stephens was code 99232 (hospital e&m - subsequent), 509 times for 142 patients. In total Jeffrey L Stephens billed 971 services in 18 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-07-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 509 | 142 | $58.24 | $30K |
| 99213 Office E&M - Established | Office | 159 | 90 | $56.06 | $8,913 |
| 99222 Hospital E&M - Initial | Facility | 96 | 90 | $95.91 | $9,207 |
| 99221 Hospital E&M - Initial | Facility | 59 | 56 | $62.45 | $3,685 |
| 99214 Office E&M - Established | Office | 25 | 24 | $81.76 | $2,044 |
| 99223 Hospital E&M - Initial | Facility | 22 | 21 | $126.65 | $2,786 |
| 99233 Hospital E&M - Subsequent | Facility | 19 | 18 | $85.84 | $1,631 |
By year: 2022 $63K for 1,033 services; 2023 $70K for 1,094 services; 2024 $60K for 971 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey L Stephens prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 808 prescriptions and refills. In total Jeffrey L Stephens wrote 3,810 Medicare prescriptions that cost $7.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 808 | 810 | 102 | $3.3M |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 249 | 251 | 29 | $1.2M |
| Tivicay Dolutegravir Sodium | 150 | 150 | 17 | $405K |
| Prezcobix Darunavir/Cobicistat | 148 | 148 | 17 | $359K |
| Amlodipine Besylate Generic | 146 | 200 | 26 | $315 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 138 | 152 | 17 | $613K |
| Atorvastatin Calcium Generic | 136 | 177 | 27 | $416 |
| Dovato Dolutegravir Sodium/Lamivudine | 109 | 109 | 13 | $334K |
| Descovy Emtricitabine/Tenofov Alafenam | 101 | 101 | 12 | $222K |
| Trazodone Hcl Generic | 87 | 91 | 13 | $257 |
| Lisinopril Generic | 72 | 99 | 14 | $257 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 64 | 76 | 14 | $838 |
| Juluca Dolutegravir/Rilpivirine | 62 | 62 | Under 11 | $220K |
| Hydrochlorothiazide Generic | 58 | 74 | 14 | $129 |
| Doxycycline Hyclate Generic | 57 | 63 | 21 | $1,479 |
Brand drugs: 2,044 claims; generic drugs: 1,766 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey L Stephens $22K ($22K in general payments such as food, travel and fees) from 6 companies. The largest payer was Gilead Sciences, Inc. with $22K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.